2009-2010 Cancer Imaging Research Fellowship at the Dana-Farber Cancer Institute
The Dana-Farber Cancer Institute/Brigham and Women’s Hospital and Harvard Medical School Cancer Imaging Research Imaging Research Fellowship is a one-year position starting May 2009, with the possibility of a second year extension.
The Dana-Farber/ Harvard Cancer Center is designated as a Comprehensive Center by the National Cancer Institute (NCI). The Center for Biomedical Imaging in Oncology (CBIO) has recently been established to integrate the clinical and pre-clinical imaging research program at the DFCI. The CBIO research program focuses on molecular imaging, the use of CT, MRI, Ultrasound, PET/CT, and other imaging modalities in the testing of novel molecularly-targeted cancer therapiess and new imaging biomarkers in patients with cancer. The CBIO preclinical imaging will be performed at the new CBIO Lurie Family Imaging Center, a 14,000 square-foot dedicated preclinical imaging facility featuring preclinical MRI, optical, ultrasound, CT, and microPET/CT scanners. .CBIO also serves as a central image analysis core laboratory for various local, national and global clinical trials.
The Research Fellow will participate in the multi-disciplinary research activities of CBIO. The primary responsibilities of the Research Fellow will include PET-CT, MRI, and CT image analysis, and other multiple research activities within our multidisciplinary group. The Research Fellow will also play a major role in the conduct of clinical imaging trials, including protocol development, and subject recruitment.
Eligibility:
MD or MD/PhD with background in Radiology and/or Nuclear Medicine; previous experience with image analysis and cancer research is preferred. Interested applicants should send a cover letter stating their career goals and interest in the position, a curriculum vitae, and three references letters to:
Annick D. Van den Abbeele, MD
Chief, Department of imaging, Dana-Farber Cancer Institute
44 Binney Street, Boston, MA 02115
Attention: Ellen Yonker
Tel: 617-632-4891
Fax: 617-582-8574
E-mail: ellen_yonker@dfci.harvard.edu
Cancer Imaging Clinical Fellowship Program at the Dana-Farber Cancer Institute
The Cancer Imaging Fellowship at the Dana-Farber Cancer Institute (DFCI) provides extensive experience in body imaging including MRI, CT, PET/CT, and US in adult patients with cancer. Subspecialty training with a focus on breast imaging and/or PET/CT is also available.
Equipment and resources:
State-of-the-art equipment includes 64-slice CT, 1.5-T and 3-T MRI, PET/CT, digital radiography, US, digital mammography and gamma camera systems. The DFCI also serves as a core imaging analysis laboratory for imaging studies performed in the context of local, national, and global clinical trials, and is in the process of creating a Center for Biomedical Imaging in Oncology (CBIO) that will oversee all pre-clinical and clinical imaging research performed at the DFCI and in a new 14,000 square feet facility dedicated to pre-clinical imaging.
Rotation Overview:
-
Approximately 60% of the fellowship entails body imaging including CT, MRI, and US imaging of the chest, abdomen, pelvis and extremities.
-
Approximately 20% of the time is divided between nuclear oncology . Nuclear oncology includes PET/CT and gamma camera imaging.
-
A breast imaging rotation may also be available, if requested.
-
Approximately 20% of the fellow’s time can be dedicated to research assuming that a detailed research project outline has been presented and approved by an attending radiologist as the project mentor. Research milestone schedules are clearly articulated and research progress is closely monitored.
-
Approximately one month of the Oncoradiology Fellowship is designated elective time. Elective time may be spent on approved research projects, or in other subspecialties at the Brigham and Women’s Hospital (BWH).
-
On-call responsibilities consist of weekend day coverage.
Teaching/Conference Responsibilities:
Participation in various clinical conferences is encouraged. Daily didactic teaching sessions are provided by DFCI Radiology faculty. Continual educational contact is provided five days per week, from 8:00AM until 6:00 PM. The Cancer Imaging Fellow is required to attend and present at the Thoracic Oncology Conference every Tuesday morning and at the Radiology-Oncology Pathology Conference every Friday morning.
Fellowship Supervision and Evaluation:
DFCI Cancer Imaging Fellows will receive continuous on-site training, teaching and feedback. Dr. Fiona Fennessy, Director of the DFCI Cancer Imaging Fellowship Program, and Dr. Annick D. Van den Abbeele, Chief of the Department of Imaging, DFCI, will evaluate the fellow’s performance.
Eligibility:
U.S. applicants must be board-eligible or board-certified in radiology. Foreign applicants must be ECFMG certified and eligible to obtain a clinical visa prior to starting the fellowship. The fellowship at DFCI is structured in accordance with the fellowship regulations as provided by the Department of Radiology at BWH.
Applicants should send c.v. and 3 reference letters (reference letters must be sent directly by the referees) to:
Fiona M. Fennessy, MD, PhD - Cancer Imaging Fellowship Program Director
Dana-Farber Cancer Institute, Department of Radiology
44 Binney Street, Boston MA 02115
Attention: Ellen Yonker
Tel: 617-632-4891
Fax: 617-582-8574
E-mail: ellen_yonker@dfci.harvard.edu
Nuclear Oncology/PET-CT Clinical Fellowship
Cancer Institute/Brigham and Women’s Hospital, Nuclear Medicine Oncologic Program is accepting applications from MD/MD-PhD affiliates for a one-year Nuclear Oncology/PET-CT Fellowship for July 2009 with the opportunity to extend it to a second year.
The Dana-Farber Cancer Institute is designated as a comprehensive center by the National Cancer Institute. The clinical fellowship will provide physicians with advanced clinical imaging training in oncology with a focus on PET/CT and cross-sectional imaging. Fellows also have the opportunity to participate in various clinical research projects. Major areas of interest include molecular imaging, evaluation of molecularly-targeted drugs, and new PET radiopharmaceuticals, tumor metrics, and core laboratory support for local, national, and global trials. The Dana-Farber Cancer Institute is an affiliate of the Harvard Medical School Joint Program in Nuclear Medicine.
Eligibility:
Completion of the USMLE parts I, II, and III, and American Board of Radiology (ABR) and/or American Board of Nuclear Medicine (ABNM)-eligible or certified. Interested applicants should send their curriculum vitae and the names of three contacts for references or have the references sent their letter to:
Annick D. Van den Abbeele, MD
Chief, Department of Radiology, Dana-Farber Cancer Institute
44 Binney Street, Boston, MA 02115
Attention: Ellen Yonker
Tel: 617-632-4891
Fax: 617-582-8574
E-mail: ellen_yonker@dfci.harvard.edu
Oncoradiology/Breast-tract Fellowship
The breast-tract oncoradiology fellowship at the Dana-Farber Cancer Institute (DFCI) is a 12-month fellowship offered to board-eligible or board-certified radiologists. It provides in-depth knowledge of the multidisciplinary diagnostic approach to medical oncology, with a particular emphasis on breast imaging and intervention.
Structure:
The Chief of the Department of Radiology at the DFCI is. Annick D. Van den Abbeele, MD and the DFCI fellowship program is directed by Fiona Fennessy, MD, PhD. One fellow is recruited each academic year. The oncoradiology, breast imaging fellowship at DFCI is structured in accordance with the fellowship regulations provided by the Department of Radiology at Brigham and Women’s Hospital (BWH).
Rotation Overview:
Half of the oncoradiology fellowship entails body imaging. This is divided between CT, MR, with some ultrasound and plain film diagnostic studies and PET-CT. MR encompasses primarily abdominal and pelvic imaging, but also chest and musculoskeletal imaging. Nuclear oncology imaging services includes two PET-CTs, and plays an important role in cancer staging, restaging, follow-up, and monitoring of therapeutic response to standard and innovative therapies at the forefront of molecular imaging. Many of the important new therapies are being tested in clinical trials at the DFCI, and the fellow is exposed to current clinical treatments, as well as new investigational treatments including molecular-targeted therapies.
30% of this fellowship position focuses on breast imaging. This encompasses mammography (screening and diagnostic), MRI of the breast and image-guided interventions in the breast. Time is spent both at DFCI and BWH.
Research:
The fellow is allotted a day free of clinical responsibilities (dedicated 20% research time) to partake in a research project, in whatever area is on interest to them, mentored by a radiology attending. However, research progress is closely monitored and timeframes for advancement with the project are strictly adhered to, as outlined by the BWH radiology fellowship guidelines.
Elective Time:
There is one month of elective time. This may be spent in research, or in subspecialties such as cross-sectional interventional radiology, vascular–interventional radiology or neuroradiology at the Brigham and Women's Hospital.
Teaching:
There are many lecture series and conferences available to the fellow. Daily didactic teaching sessions are provided by the staff of the DFCI radiology department. BWH radiology noon-conferences are also available on a daily basis, although this conference time is not protected while on the clinical schedule Continual educational contact is provided 5 days a week, from 8 AM until 6 PM.
Fellowship Supervision and Evaluation:
The staff radiologists at the DFCI provide on-site training and teaching. Fellows are continually evaluated throughout the year, and are provided constant feedback.Fiona M. Fennessy,MD, PhD, Robin Birdwell, MD and Annick D. Van den Abbeele, MD oversee the fellow’s performance in the oncoradiology fellowship program.
Fiona M. Fennessy, MD, PhD
Fellowship Program Director
Department of Radiology, Dana-Faber Cancer Institute
44 Binney Street, Boston, MA 02115
Attention: Ellen Yonker
Fellowship Coordinator
Tel: 617-632-4891
Fax: 617-582-8574
Email: ellen_yonker@dfci.harvard.edu
Send Feedback to: 
